RECENT PLACEMENT

Occam Recruits Translational Leader for Gene Editing Leader Mammoth

Occam Recruits Translational Leader for Gene Editing Leader Mammoth

In February of 2024, Occam recruited Gabor Veres, PhD, as Senior Vice President of Translational Sciences for Mammoth Biosciences, a biotech developing diagnostic tests and therapies using CRISPR systems.  The company was founded in 2017 by Jennifer DoudnaTrevor Martin, Janice Chen, and Lucas Harrington of Stanford University and is richly funded by numerous investors, including Mayfield8VCRedmile GroupForesite CapitalTim CookBrooks Byers, and Jeff Huber

Gabor Veres is a highly experienced professional who has led preclinical research and early development for an impressive array of biotechnology companies and developed cell and gene therapy products. He most recently served as the Chief Scientific Officer at Vedere Bio, prior to which he was the Vice President and Head of Genetic Therapy Research at BioMarin. Before joining BioMarin, he worked at bluebird bio as the Vice President of Pre-clinical Research, where he initiated and coordinated numerous research programs aimed at viral gene delivery to treat genetic and acquired diseases. Veres has successfully led several projects from pre-clinical research to clinical development, including ZYNTEGLO® and SKYSONA™. 

Recent Placements

  1. Paul Thibodeau as CBO of Hotspot
  2. Wildon Farwell as CMO of Dyne
  3. Paul Audhya as CMO of KalVista
  4. Mark McDonough as CEO of ChromaCode
  5. Matthew Gall as CFO of iTeos Therapeutics
About Occam Global

Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide.  Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.  Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression.  Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.